The recent publication "Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections," published in the journal Advanced Materials, was highlighted in this week's issue of Science Translational Medicine. Prof. Christoper M. Jewell, Associate Professor & Damon Runyon-Rachleff Innovator at the Fischell Department of Bioengineering in University of Maryland – College Park, authored the Editor's Choice article. You can access the article entitled "Resistance is Futile" here.
Ester Kwon et al. reported that antimicrobial peptide packaged in a silicon nanoparticle can dramatically reduce the number of bacteria in the lungs of mice infected with Pseudomonas aeruginosa, a disease causing Gram-negative bacterium that can lead to pneumonia. You can access coverage of this article in MIT News here and the original publication here.